IL‐10 vs placebo
CDAI <150 at 24 weeks · induction of remission in Crohn's disease
IL‐10 showed no clear difference in clinical remision (CDAI<150) compared with placebo (moderate certainty).
1 finding from 1 review
- Recombinant human interleukin 10 for induction of remission in Crohn's disease 2010 · Cochrane Headline outcomes onlyRR 1.29 [0.79, 2.11]3 studies · 470 participantsModerate